Evidence map›Paper›PMID 40219225›Full record

ArticlePolymers2025

Self-Made Cyclodextrin Inclusion Complexes for Enhanced Mechanical Properties of Polycaprolactone Composites.

Yanji Yin, Xiaotong Wang, Jiayan Zhang, Wenyan Wang, Rui Han

Abstract read
In one paragraph

Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yanji YinKey Laboratory of Materials and Surface Technology (Ministry of Education), School of Materials Science and Engineering, Engineering Research Center of Intelligent Air-Ground Integration Vehicle and Control, Xihua University, Chengdu 610039, China.
Xiaotong WangKey Laboratory of Materials and Surface Technology (Ministry of Education), School of Materials Science and Engineering, Engineering Research Center of Intelligent Air-Ground Integration Vehicle and Control, Xihua University, Chengdu 610039, China.
Jiayan ZhangKey Laboratory of Materials and Surface Technology (Ministry of Education), School of Materials Science and Engineering, Engineering Research Center of Intelligent Air-Ground Integration Vehicle and Control, Xihua University, Chengdu 610039, China.
Wenyan WangKey Laboratory of Materials and Surface Technology (Ministry of Education), School of Materials Science and Engineering, Engineering Research Center of Intelligent Air-Ground Integration Vehicle and Control, Xihua University, Chengdu 610039, China.
Rui HanKey Laboratory of Materials and Surface Technology (Ministry of Education), School of Materials Science and Engineering, Engineering Research Center of Intelligent Air-Ground Integration Vehicle and Control, Xihua University, Chengdu 610039, China.ORCID 0000-0002-7535-567X

Funding

Talent Recruitment Program of Xihua University Z222079the open subject from Technology Innovation Center of Hydrogen Storage-Transportation and Fueling Equipments, State Administration for Market Regulation TICHE2023001
6 · The paper itself

Abstract

Polycaprolactone (PCL) is a widely used polymer in biomedical applications due to its excellent processability, ductility, and biodegradability. However, single-component PCL devices often fail to meet the multifunctional and high-performance demands of modern biomedical devices. In this study, we introduced biodegradable and environmentally friendly cyclodextrin (CD) to fabricate CD inclusion complexes with low-molecular-weight polycaprolactone (LPCL). These complexes were incorporated into commercial PCL to prepare the resulting composites. The effects of PCL molecular weight and CD type on the properties and inclusion ratios of the complexes were systematically investigated. Among the tested complexes, the one formed with LPCL (Mw = 8 × 10

Indexed as

cyclodextrininclusion complexesmechanical propertypolycaprolactone

Identifiers

PMID40219225
PMCPMC11991177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.